Summary The effect of basement membrane components (laminin, fibronectin and type IV collagen) and lung fibroblasts on type IV collagenase and plasminogen activator activity was investigated in a primary HSV-2-induced hamster fibrosarcoma, and its in vivo derived sublines and in vitro derived clones of varying metastatic potential.
Metastasizing tumour cells traverse epithelial and endothelial basement membranes (BM) whilst extravasating from the circulation and invading the target organ (Thorgeirsson et al., 1984) . Type IV collagenase, a metalloproteinase, has been demonstrated to be the specific enzyme capable of degrading type IV collagen, the structural back bone of the BM (Timpl et al., 1981; Liotta et al., 1980) . Other components of the BM are non-collagenous glycoproteins such as laminin and fibronectin (Timpl et al., 1979; Carlin et al., 1981; Kanwar et al., 1979) .
Several tumours have previously been demonstrated to secrete increased quantities of type IV collagenase compared with their non-malignant cell type (Salo et al., 1982) . The metastatic potential of tumour cells has also been shown to correlate with their in vitro ability to degrade type IV collagen (Liotta et al., 1980 (Liotta et al., , 1981 Nakajima et al., 1987) and more recently the increased expression of type IV collagenase activity has been associated with the increased metastatic activity of murine tumour cell hybrids (Turpeeniemi-Hujanen et al., 1985) .
In a recent report from this laboratory, we were unable to correlate type IV-collagen-degrading metalloproteinase activity of a spontaneously metastatic HSV-2 induced hamster fibrosarcoma with metastatic potential, Thus, sublines established from secondary lung nodules occurring following resection of the primary tumour, and in vitro derived clones of the parental tumour, of established metastatic potential, were heterogenous with respect to type IV collagenase activity . Attachment to the basement membrane is a prerequisite to dissolution of the extracellular matrix (Liotta et al., 1977 ) and experiments performed in vitro have demonstrated tumour cell binding to the basement membrane using laminin as the attachment factor (Terranova et al., 1982) . We have, therefore, assessed the influence of BM components, and lung fibroblasts, on the secretion of type IV collagenase in sublines and clone of defined metastatic ability in the hamster tumour model (Walker et al., 1982; Teale et al., 1983 Teale et al., ,1984 Khidair et al., 1986) . The secretion of plasminogen activator (PA), a serine protease capable of degrading serum plasminogen converting it to plasmin, which in turn is capable of degrading fibrin and laminin (Carlson et al., 1984; Liotta et al., 1981) , was also investigated in this system.
Materials and methods

Animals
Male, Syrian golden hamsters, aged between 6 and 10 weeks and weighing 60-90 grams were used in all experiments. The animals were obtained from a closed randomly bred colony at the University of Sheffield and have previously been shown to be syngeneic by skin grafting experiments (Potter & Jennings, unpublished) and mixed lymphocyte reactions in vitro (Teale, unpublished) .
Tumours
The HSV-2-333-2-26 cell line (parent) used in the current study was originally obtained by in vitro transformation of hamster embryo fibroblasts with inactivated HSV-2; this cell line was provided by Dr F. Rapp (Department of Microbiology, Pennsylvania State University, Hershey, USA).
The four sublines met B, met C, met F and met G were derived from lung nodules in hamsters whose primary parent load had previously been resected; following in vivo passage, in vitro cultures were established and used within 10 passages. Clones S4A and S9E were obtained following double cloning of the parental cell line by the limiting dilution method . Some of the characteristics of the in vivo and in vitro derived cell lines have been reported previously (Walker et al., 1982; Teale et al., 1983 Teale et al., ,1984 Khidair et al., 1986) and are summarised in Table I .
Lung fibroblasts
Lungs from one-week old baby hamsters were minced with forceps and scalpel, digested with 0.25% trypsin (w/v) containing DNAase (0.02% w/v) and the cell suspensions seeded into 25cm3 plastic tissue culture flasks in Complete Modified Eagles Medium (CMEM) supplemented with 10% foetal calf (Teale et al., 1984; .
Cell cultures
All cell lines were maintained in CMEM, and incubated at 37°C in a humidified atmosphere containing 5% CO2.
Collection of media and preparation for enzyme assay Four T175cm2 sub-confluent flasks of each cell line were washed X3 with Hanks balanced salt solution (HBSS) and incubated in 25 ml of serum-free CMEM for 24 hrs. The media was collected, centrifuged to remove free cells and the supernatant concentrated 100-fold with ammonium sulphate precipitation (0-60%) and dialysed against 0.2 M NaCl, 0.05 M Tris HCI, 5 mM CaCI2 pH7.6 at 4°C. This preparation (1.Oml) was stored at -20°C prior to assay for type IV collagenase.
Preparation of substrates
Type IV collagen was biosynthetically labelled with 14C-proline (5 mCi mmol -1) from organ cultures of ESH sarcoma as described previously and purified according to Liotta et al. (1981) . Substrate preparation was checked for purity by SDS-PAGE and stored frozen in 0.5 M acetic acid until use.
Type IV collagenase assay BM collagenase activity was assayed as described previously (Liotta et al., 1981; Turpeeniemi-Hujanen et al., 1985; by using soluble 3H-proline-labelled type IV procollagen. The substrate, 6000cpm, was added in 50yl of reaction buffer (specific activity of 240cpmpg-1 protein).
The enzyme sample was activated with 10 ugml-P of trypsin for 10min at 37°C and assayed in the presence of 50pgml-1 SBTI for 1Oh at 37°C. These conditions have previously been demonstrated to activate latent hamster fibrosarcoma type IV collagenase . The reaction was terminated by inactivating the samples at 4°C for 90min in the presence of 20p1 bovine serum albumin (5mgml-1), 0.6% trichloroacetic acid (TCA) and 0.03% tannic acid. The undigested TCA precipitated substrate was centrifuged and the radioactivity of the supernatant counted in a f-scintillation counter. The amount of degraded type IV collagen was then calculated from the total amount of radio-labelled substrate (8000 cpm). Bacterial collagenase was used as a positive control to achieve maximum degradation levels whilst samples without enzyme or with EDTA or STB1 alone were included as negative controls.
Experiments to characterise the enzyme activity by SDS polyacrylamide gel electrophoresis indicated the Type IV pro-collagen substrate to yield two sets of cleavage products (results not shown) consistent with cleavage products reported in other systems (Liotta et al., 1981; . Cell counts, using a haemocytometer, were performed on trypsinised cell monolayers plus the centrifuged pellet of the collection media.
Assay for plasminogen activator Preparation Of 125I-labelled fibrin plates
Bovine fibrinogen (Sigma F8630) was purified from contaminating traces of plasminogen by the precipitation method and subsequently radiolabelled with 1251I. Two hundred ml of 1OOugml-P purified fibrinogen solution was mixed with the content of one vial of 125I human fibrinogen (11OyCi) that had been resuspended in phosphate-buffered saline (PBS). Two hundred pl of the radiolabelled fibrinogen solution was added to each well of a 24-well tissue culture plate (Falcon 3047), dried at 37°C and exposed to ultraviolet (UV) light for 30min to minimize the risk of contamination. Plates were stored at -20°C until required for use.
Preparation of plasminogen
Plasminogen was extracted from rabbit serum by affinity chromatography with lysine sepharose 4B as previously described. Plasminogen was titrated by the addition of increasing quantities of plasminogen to a constant amount of supernatant from the cell culture. The amount of plasminogen that gave maximum release of radioactivity was determined and used in all subsequent experiments (100p1).
Extracellular PA activity
In vitro cell cultures were prepared from in vivo tissue (normal or tumour) as previously described. The cells were cultured in 60-mm plastic petri dishes (Sterilin, 303) in 5ml of Hams FIO media (10% NBCS) at a concentration of 3 x 104 cells ml-1 and incubated for 24h at 37°C (5% CO /95% air). The cells were washed twice with PBS to remove traces of serum and incubated with 5ml Hams FIO media (serum-free) for an additional 5h. The supernatants were centrifuged at 200rpm for 5min, collected, and stored at -20°C. The remaining cells were treated with trypsin and counted so that activities could be expressed with respect to the cell number. The fibrinolytic assay was performed by incubating 400 p1 of the supernatants with 100 p1 of plasminogen for 1 h, followed by a transfer to 125I-labelled fibrin plates. The fibrin plates had previously been incubated with Hams FIO media for 2h to allow the conversion of fibrinogen to fibrin through the action of thrombin present in the NBCS of the medium. Any traces of serum were removed from the plates by washing two times with PBS. The plates were then incubated with the supernatants at 37-C (5% C02/95% air) for 8h. The supernatants were then transferred to plastic vials and counted for one minute in an alpha-spectrophotometer. The residual fibrin present in the plates was digested with 0.1% trypsin for 24h. Thus, the degradation of fibrin by the supernatants in the first 8 h was expressed as a percentage of the total fibrin in each well using the following formula: The supernatants were assayed in triplicate. Media that had not been incubated with cells were incubated with plasminogen and used as control, to exclude any spontaneous release of radioactivity from the labelled plates. PA activity of the hamster fibrosarcoma cell lines has previously been shown to be of a secreted form and not cell bound (Khidair et al., 1986) .
Reagents
Laminin and fibronectin were obtained from Collaborative Research, Spring Street, Lexington, Mass. Type IV collagen was purified from the ESH sarcoma as described by Timpl et al., 1979 , and the purity was demonstrated by gel electrophoresis.
Addition of laminin, fibronectin and type IV collagen to culture cells Laminin and fibronectin were reconstituted to the required concentration in sterile distilled water. Tissue culture flasks (175 cm2) and 50mm plastic petri dishes were coated by adding sufficient volume to cover the substrate surface, incubated at room temperature for 45 min, drained and allowed to dry. Type IV collagen was obtained in phosphate buffered saline and coating of the substrate was performed as above.
Laminin, fibronectin and type IV collagen previously diluted in serum-free medium were also added directly to serum-free collection supernatants.
Results
Effect of laminin, fibronectin and type IV collagen on the secretion of type IV collagenase by the parent tumour and its subline met B
The parental cell line and met B cells were grown to subconfluency prior to adding laminin (1-8pgml-1), fibronectin (1-20 pg ml -1) or type IV collagen (1-20 pg ml 1) to the serum-free culture supernatants (see Figure 1) .
Type IV collagenase activity was increased up to 100% for the parent cell line in the presence of laminin. Fibronectin and type IV collagen did not modify the type IV collagenase activity at any of the concentrations used. Precoating tissue culture flasks with fibronectin or type IV collagen was also ineffective at altering the expression of type IV collagenase (results not shown).
Similar results were obtained for met B cells. Thus, increases in type IV collagenase activity of up to 300% were obtained in the presence of laminin but fibronectin and type IV collagen had no effect (Figure 1 ). Bovine serum albumin Figure 1 Type IV collagenase activity for the parent and met B cell lines. Laminin E (8upgml-1), fibronectin a (20pgml-1) and type IV collagen Ol (20pgml-1) was added to the 24 h serumfree culture media. BSA * (10 pg ml -) was included as a negative control in addition to the untreated E control flasks.
BSA, fibronectin and type IV collagen at lower concentrations did not alter type IV collagenase activity' Pre-treatment of flasks with laminin, fibronectin and type IV collagen gave similar results to the addition of BM components to the collection media.
(BSA) was included in all experiments (10pgml-1) as a negative control. Experiments using different concentrations of laminin showed type IV collagenase activity to be dose-dependent, the saturating concentration being in excess of 8 pg ml-1 (Figure 2) . A concentration of 6.0pgml-1 laminin added to the serum-free culture medium was used in the subsequent series of experiments.
Basal levels and the effect of laminin on the secretion of type IV collagenase for high and low metastatic cell lines Table I shows the origin and metastatic profile of the cell lines investigated and their basal level of type IV collagenase activity. Thus, low/non-metastatic cell lines (parent and S9E) produced intermediate levels of type IV collagenase. The highly metastatic cell lines (met B, met F and S4A) however, consistently expressed less type IV collagenase activity than the parental cell line. In contrast, the low/non-metastatic cell lines (met C and particularly met G) secreted more type IV collagenase activity compared to the primary parent tumour. The parental cell line, met C, met G and S9E (low/nonmetastatic) and met B, met F and S4A (highly metastatic) were grown to subconfluency prior to adding laminin (6Mgml-1) or BSA (6ygml-1) to serum-free culture collection media (see Figure 3) .
The presence of laminin increased type IV collagenase activity by up to 100% for the parent cell line and the in vitro clone, S4A. Met B and met F (in vivo sublines) showed increased expression of BM collagenase by 220% and 190% respectively. Met C and met G (in vivo sublines) and S9E (in vitro clone) showed no increase in type IV collagenase expression following the addition of laminin (Figure 3 ).
The effect of laminin, fibronectin and type IV collagen on PA activity for the hamster tumour cell lines
The basal level of PA activity for the cell lines studied, together with their origin and metastatic profile are given in Table I . All cell lines secreted similar levels of PA activity demonstrating no correlation between the secretion of PA and their metastatic propensity. Laminin, fibronectin and type IV collagen, used at the concentrations described for type IV collagenase, were either added to the culture media or used to coat 60mm plastic petri dishes. Neither laminin, fibronectin nor type IV collagen-coated petri dishes, at any of the concentrations, affected the PA activity of the parent or the met B cell line (results not shown). Similarly, laminin, fibronectin or type IV collagen added to the culture media either for the 24h prior to the 5 h serum-free collection period, during the serum-free collection period or present during the overnight culture period and during the serum-free collection period, did not affect the level of PA activity for any of the cell lines (see Table II Serum-free collection medium was harvested after 5h and 24h incubation at 37°C and assayed for type IV collagenase or PA activity. The results, (see Table III Met G S4A S9E Figure 3 The effect of laminin on secreted type IV collagenase activity for the parent tumour and its in vivo sublines and in vitro clones. Laminin (6 jug ml 1) and BSA (6 gg ml -1) were added to the serum-free 24 h collection media. After this period the media was harvested for type IV collagenase assay and a cell count performed. The enzyme activity was calculated as cpm 10 -6 cells as percentages of the BSA control which was adjusted to 100 cpm 10-6 cells. predicted value (sum) after a 24 h collection period. No difference was observed after a 5 h collection period. Serumfree culture supernatants were also assayed for PA activity (see Table IV ). After 24h coculture (parent or met B cells plus lung fibroblast) the PA activity was similar to the sum of PA activity for lung fibroblasts and tumour cells grown independently for 24 h. At 5 h coculture, however, PA activity for met B tumours and lung fibroblasts was significantly higher than the predicted sum. Similar results were obtained for the parent cell line although the increase was not statistically significant (see Table IV ).
Discussion
Previous studies have reported a correlation between the change from the normal to the malignant cell phenotype and the ability to secrete the basement membrane degrading metalloproteinase, type IV collagenase (Salo et al., 1982) . A similar correlation has been reported between non-metastatic and metastatic cell types (Liotta et al., 1980; Nakajima et al., 1987) and more recently the increased expression of type IV collagenase activity has been correlated with the increased metastatic capacity of murine tumour cell hybrids (Turpeeniemi-Hujanen et al., 1985) . In a previous report from this laboratory, we were able to confirm that a HSV-2-induced hamster fibrosarcoma tumour cell line and sublines derived from its in vivo metastases, or its in vitro derived clones were able to express type IV collagenase activity . No correlation between metastatic propensity and the level of type IV collagenase activity, however, was noted. This may be attributable to the immunological status of non-metastatic lines, since Turpeeniemi-Hujanen et al. (1985) found that non-metastatic murine tumour cell lines which expressed type IV collagenase activity were able to metastasize in nude mice.
In N, '\ N" "I N,\\1\ \\\ i x x X% xxx x x x x x x x -., --, -., -., 1, --% --% x --., --% --, I%A~~~~~ fibronectin, are assembled (Timpl et al., 1979 (Timpl et al., ,1981 Carlin et al., 1981; Kanwar & Farquar, 1979) . Laminin serves as an attachment protein for endothelial and epithelial cells (Timpl et al., 1979; Lesot et al., 1983; Kefalides et al., 1979) and it has been shown that metastatic tumour cells in vitro bind to the basement membrane via laminin prior to degradation of type IV collagen (Terranova et al., 1982) . In a recent communication (Turpeeniemi-Hujanen et al., 1986 ) the binding of laminin to human melanoma cells, the HT fibrosarcoma and the B16 melanoma, increased type IV collagenase activity by up to 300% in these cell lines.
In addition to this, a monoclonal antibody against the human laminin receptor blocked the effect of laminin on type IV collagenase activity. This study would, therefore, suggest that the binding of laminin to a tumour cell, which mimics the binding to a basement membrane, induces the secretion of type IV collagenase and the dissolution of the basement membrane (Turpeeniemi-Hujanen et al., 1986) .
We have found that laminin added to the serum-free culture media can augment the expression of type IV collagenase in metastatic but not non-metastatic cell lines. Non or weakly metastatic cell lines, however, appear to express a basal level of type IV collagenase which is greater than that of their metastatic sister cell lines. This would suggest that specific control of release of type IV collagenase at the time of tumour cell attachment to the basement membrane, via interaction with laminin, may be more important than the continued background secretion of type IV collagenase.
These results are in keeping with those of Terranova et al., 1982 , who demonstrated enhanced metastatic capacity of tumour cells selected by attachment to laminin. Fibronectin did not select for the metastatic phenotype.
In addition to studying the effect of BM components on type IV collagenase we also report on their effect on plasminogen activator (PA) secretion. PA induces the activation of plasminogen giving rise to plasmin which has been associated with the ability of tumour cells to metastasize (Carlson et al., 1984; Wang et al., 1980) possibility by its ability to degrade laminin (Liotta et al., 1981) . We have previously shown that the hamster tumour cell lines used here are able to recrete PA but no correlation between the level of PA secretion and the metastatic profile was found (Khidair et al., 1986) . We are now able to report that the addition of laminin, fibronectin or type IV collagen to the tumour cell lines failed to alter the expression of plasminogen activator activity. The initial inter-reaction between tumour cells and lung fibroblasts during in vitro coculture, however, did augment PA activity, but appeared to inhibit type IV collagenase expression. It is possible that normal cells are able to suppress type IV collagenase activity, and this mechanism may serve to down-regulate type IV collagenase activity at an appropriate stage of the metastatic processs. On the other hand initial interaction of tumour cells with normal lung fibroblasts (in vitro) caused an initial increase in PA activity (it is, however, undetermined whether tumour cells or fibroblasts are responsible for this release) and the interaction of metastasizing tumour cells with lung fibroblasts may initiate PA and induce the internal degradation of the BM via laminin degradation. It is generally believed that the physiological turnover of basement membranes is controlled by a cascade of proteases (Salo et al., 1982; Turpeeniemi-Hujanen et al., 1986) , type IV collagenase and PA being two examples. The control of these proteases is not fully understood but it would appear from the present study, and the literature, that the binding of laminin by tumour cells may be one controlling factor for type IV collagenase expression. PA would appear not to be enhanced at the basement membrane but may serve as a second thrust of enzyme degradation, possibly from the 'internal' side of the basement membrane barrier upon interaction with cell types confined by the basement membrane.
